Therapeutic efficacy and renal effects of cefonicid in the treatment of difficult urinary tract infections.
EFFICACY, renal effects and nephrotoxicity of the cephalosporin cefonicid (CEF) were evaluated in 11 adult patients with urinary tract infection and varying renal function (creatinine cl 19-161 ml/min, mean 75). CEF was administered i.m. for 7 days at a daily dose adjusted to renal function of the patients.


RESULTS
At the 4th day and at the end of the treatment urine cultures were negative in all cases; a recurrence of the infection was observed in 4 patients 10 days after completion of therapy. Renal effects and nephrotoxicity: CEF neither modified plasma creatinine, urea, uric acid and their renal clearances nor glomerular filtration rate. Only the urinary enzyme activity of alanine aminopeptidase increased slightly at the end of the therapy. It returned to basal values in the post-treatment period. Urinary enzyme activities of gamma-glutamyltransferase, alkaline phosphatase, N-acetyl-beta-D-glucosaminidase and lysozyme were unmodified during and after treatment with CEF. These results indicate that CEF is an effective antimicrobial agent which does not influence renal function, nor cause nephrotoxic effects.
Donadio
C
C
Nefrologia Medica, Istituto di Clinica Medica 2, University of Pisa, Italy.
Tramonti
G
G
Garcea
G
G
Costagli
M
M
Lucchetti
A
A
Giordani
R
R
Paizis
G
G
Pierotti
R
R
Falcone
G
G
Bianchi
C
C
D000328:Adult; D000368:Aged; D015790:Cefonicid / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins; D015790:Cefonicid